Mitsui Masao, Sekito Takanori, Maruhashi Mai, Maruyama Yuki, Iwata Takehiro, Tominaga Yusuke, Katayama Satoshi, Nishimura Shingo, Bekku Kensuke, Araki Motoo, Hirakawa Hidetada, Sadahira Takuya
Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1, Shikata-cho, Kita-ku, Okayama 700-8558, Japan.
Department of Bacteriology, Graduate School of Medicine, Gunma University, 3-39-22, Showa-machi, Maebashi Gunma 371-8511, Japan.
Antibiotics (Basel). 2025 May 6;14(5):468. doi: 10.3390/antibiotics14050468.
Urinary tract infection (UTI) is predominantly caused by uropathogenic (UPEC). Previous studies have reported that the fimbriae of UPEC are involved in virulence and antimicrobial resistance. We aimed to analyze the fimbrial gene profiles of UPEC and investigate the specificity of these expressions in symptomatic UTI, urinary device use, and levofloxacin (LVFX) resistance/extended-spectrum beta-lactamase (ESBL) production. A total of 120 UPEC strains were isolated by urine culture between 2019 and 2023 at our institution. They were subjected to an antimicrobial susceptibility test and polymerase chain reaction (PCR) to identify 14 fimbrial genes and their association with clinical outcomes or antimicrobial resistance. The prevalence of the papG2 gene was significantly higher in the symptomatic UTI group by multivariate analyses (OR 5.850, 95% CI 1.390-24.70, = 0.016). The prevalence of the c2395 gene tended to be lower in the symptomatic UTI group with urinary devices (all < 0.05). In LVFX-resistant UPEC strains from both the asymptomatic bacteriuria (ABU) and the symptomatic UTI group, the expression of the , , , and genes tended to be lower (all < 0.05). The fimbrial genes of UPEC are associated with virulence and LVFX resistance, suggesting that even UPEC with fewer motility factors may be more likely to ascend the urinary tract in the presence of the urinary devices. These findings may enhance not only the understanding of the virulence of UPEC but also the management of UTI.
尿路感染(UTI)主要由尿路致病性大肠杆菌(UPEC)引起。先前的研究报道,UPEC的菌毛与毒力和抗菌药物耐药性有关。我们旨在分析UPEC的菌毛基因谱,并研究这些表达在有症状的UTI、使用导尿管以及左氧氟沙星(LVFX)耐药/产超广谱β-内酰胺酶(ESBL)方面的特异性。2019年至2023年期间,我们机构通过尿液培养共分离出120株UPEC菌株。对它们进行了抗菌药物敏感性试验和聚合酶链反应(PCR),以鉴定14种菌毛基因及其与临床结果或抗菌药物耐药性的关联。多因素分析显示,有症状的UTI组中papG2基因的流行率显著更高(比值比5.850,95%置信区间1.390 - 24.70,P = 0.016)。在使用导尿管的有症状UTI组中,c2395基因的流行率往往较低(均P < 0.05)。在无症状菌尿(ABU)组和有症状的UTI组的LVFX耐药UPEC菌株中,focG、focD、fimA和fimH基因的表达往往较低(均P < 0.05)。UPEC的菌毛基因与毒力和LVFX耐药性相关,这表明即使是运动因子较少的UPEC,在存在导尿管的情况下也更有可能上行至尿路。这些发现不仅可能增进对UPEC毒力的理解,还可能改善UTI的管理。